Desmarais LLP earned 2024 LMG Life Sciences rankings in the “General Patent Litigation” and “Hatch-Waxman Patent Litigation (Branded)” categories, and firm partners John Desmarais, Paul Bondor, and Justin Wilcox were selected as “Life Sciences Stars.”
Recent life sciences patent litigation successes include Desmarais LLP winning $429.5 million in total damages for Ravgen’s prenatal genetic testing technology, earning a favorable settlement for Auris Health that ended litigation involving robotic surgical and diagnostic devices, and securing a no-violation finding before the International Trade Commission for Croma-Pharma related to a Botox products dispute.
The annual LMG Life Sciences rankings honor the industry’s leading firms and attorneys within four practice areas – financial and corporate, intellectual property, non-IP litigation and enforcement, and regulatory. Researchers review firms’ cases, receive input from industry practitioners, gather client feedback, and conduct independent research, as well as grade firms based on the complexity and innovation of their work.
See the full LMG Life Sciences rankings
Desmarais LLP Secures $44.9M Jury Verdict for IBM in Tech Patent Trial
Patent Trial for the Plaintiff
Desmarais LLP won a $44.9 million verdict for IBM following a jury trial that found the video game developer Zynga Inc. had infringed two of its patents related to interactive...
MORE
